Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices 24207 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2013–0005; NIOSH–263] 

Request for Information About 

Diethanolamine (CAS No. 111–42–2) 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for information. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) intends to 

evaluate the scientific data on 

diethanolamine, and develop 

appropriate communication documents, 

such as a Criteria Document, which will 

convey the potential health risks, 

recommended measures for safe 

handling, and establish an updated 

Recommended Exposure Limit (REL). 

The current NIOSH REL for 

diethanolamine is 3 parts per million 

(ppm) as a time-weighted average 

(TWA) concentration for up to a 10-hr 

work shift during a 40-hr workweek. 

NIOSH is requesting information on 

the following: (1) Published and 

unpublished reports and findings from 

in vitro and in vivo toxicity studies with 

diethanolamine; (2) information on 

possible health effects observed in 

workers exposed to diethanolamine, 

including exposure data and the 

method(s) used for sampling and 

analyzing exposures; (3) description of 

work tasks and scenarios with a 

potential for exposure to 

diethanolamine; (4) information on 

control measures (e.g. engineering 

controls, work practices, personal 

protective equipment, exposure data 

before and after implementation of 

control measures) that are being used in 

workplaces with potential exposure to 

diethanolamine; and (5) surveillance 

findings including protocol, methods, 

and results. 

Public Comment Period: Comments 

must be received by June 24, 2013. 

ADDRESSES: You may submit comments, 

identified by CDC–2013–0005 and 

Docket Number NIOSH–263, by either 

of the two following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, MS–C34, 4676 

Columbia Parkway, Cincinnati, OH 

45226. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

(CDC–2013–0005; NIOSH–263). All 

relevant comments received will be 

posted without change to http:// 

www.regulations.gov, including any 

personal information provided. All 

electronic comments should be 

formatted as Microsoft Word. Please 

make reference to CDC–2013–0005 and 

Docket Number NIOSH–263. 

FOR FURTHER INFORMATION CONTACT: 

Jennifer Reynolds, MPH, NIOSH, Robert 

A Taft Laboratories, MS–C32, 4676 

Columbia Parkway, Cincinnati, OH 

45226, telephone (513) 533–8531. 

SUPPLEMENTARY INFORMATION: 

Diethanolamine is a highly reactive 

compound. It decomposes on burning 

producing toxic fumes. Diethanolamine 

reacts violently with oxidants and 

strong acids. Diethanolamine is used to 

produce surface active agents widely 

used in soaps, cosmetics and personal 

care items. It also has other uses 

including as an absorbent in gas 

purification, as a dispersing agent in 

agricultural chemicals, a corrosion 

inhibitor and wetting agent in 

metalworking fluids. 

The annual production of 

diethanolamine in the United States was 

estimated in 1995 to be 106,000 tons 

(Technology Planning and Management 

Corp, 2002). NIOSH estimates from the 

National Occupational Exposure Survey 

(NIOSH 1989) that the number of 

workers potentially exposed to 

diethanolamine is approximately 

830,000/year. 

Significant occupational exposures to 

diethanolamine are through the skin 

(dermal) and via inhalation (lung) 

during the use of lubricating liquids in 

various processes in machine building. 

Chronic exposure to diethanolamine can 

cause skin sensitization. 

Diethanolamine is also corrosive to the 

eyes. The current REL for 

diethanolamine is 3 ppm as a TWA 

concentration for up to a 10-hr work 

shift during a 40-hr workweek. The 

NIOSH REL was established as a result 

of testimony submitted to the 

Occupational Safety and Health 

Administration (OSHA) on their 

proposed rulemaking of Air 

Contaminants in 1988. Currently, 

concentrations below the REL can be 

detected and quantified. As part of an 

effort to identify RELs that may not be 

adequate to protect workers from 

adverse health effects due to exposure, 

NIOSH is reexamining the REL for 

diethanolamine. There is no OSHA 

permissible exposure limit (PEL) for 

diethanolamine. The American 

Conference of Governmental Hygienists 

(ACGIH®) threshold limit value 

(TLV®)—TWA for diethanolamine is 1 

mg/m3 (inhalable fraction and vapor), 

with a Skin notation (indicating danger 

of cutaneous absorption), and an A3 

carcinogenicity classification 

(confirmed animal carcinogen with 

unknown relevance to humans). 

NIOSH seeks to obtain materials, 

including published and unpublished 

reports and research findings, to 

evaluate the possible health risks of 

occupational exposure to 

diethanolamine. Examples of requested 

information include, but are not limited 

to, the following: 

(1) Identification of industries or 

occupations in which exposures to 

diethanolamine may occur. 

(2) Trends in the production and use 

of diethanolamine. 

(3) Description of work tasks and 

scenarios with a potential for exposure 

to diethanolamine. 

(4) Workplace exposure measurement 

data of diethanolamine in various types 

of industries and jobs. 

(5) Case reports or other health 

information demonstrating potential 

health effects in workers exposed to 

diethanolamine. 

(6) Research findings from in vitro and 

in vivo studies. 

(7) Information on control measures 

(e.g., engineering controls, work 

practices, PPE) being taken to minimize 

worker exposure to diethanolamine. 

(8) Educational materials for worker 

safety and training on the safe handling 

of diethanolamine. 

(9) Data pertaining to the feasibility of 

establishing a more protective REL for 

diethanolamine. 

(10) Names of substitute chemicals or 

processes being used in place of 

diethanolamine and type of work tasks. 

References 

NIOSH [1989]. National occupational 

exposure survey analysis of management 

interview responses. Vol. III. Pedersen 

DH, Sieber WK, eds. Cincinnati, OH: 

U.S. Department of Health and Human 

Services, Centers for Disease Control, 

National Institute for Occupational 

Safety and Health, DHHS (NIOSH) 

Publication No. 89–103. 

Technology Planning and Management 

Corporation [2002]. Report on 

carcinogens background document for 

diethanolamine. Prepared for the U.S. 

Department of Health and Human 

Services, National Toxicology Program: 

Research Triangle Park, NC. 


tkelley on DSK3SPTVN1PROD with NOTICES
24208 Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices 

Dated: April 18, 2013. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–09651 Filed 4–23–13; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Number: 93.676] 

Announcement of the Award of 12 

Single-Source Program Expansion 

Supplement Grants to Unaccompanied 

Alien Children’s Shelter Care Grantees 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, Department of Health and 

Human Services. 

ACTION: Announcement of the award of 

12 single-source program expansion 

grants to 10 current grantees to expand 

bed capacity and supportive services to 

the increasing number of 

unaccompanied alien children. 

SUMMARY: The Administration for 

Children and Families (ACF), Office of 

Refugee Resettlement (ORR) announces 

the award of twelve single-source 

program expansion supplement grants 

to the following ten current grantees, for 

a total of $33,653,092. 

Organization Location Amount 

Children’s Center, Inc ................................................................................................... Galveston, TX ........................................... $354,377 

BCFS Health and Human Services ............................................................................. San Antonio, TX ....................................... 11,826,867 

Heartland Human Care Services, Inc .......................................................................... Chicago, IL ................................................ 1,459,119 

Southwest Key, Inc ...................................................................................................... Austin, TX ................................................. 12,450,000 

United States Conference of Catholic Bishops ............................................................ Washington, DC ........................................ 300,000 

Lutheran Immigration Refugee Services ...................................................................... Baltimore, MD ........................................... 2,500,000 

Lutheran Social Services of the South ........................................................................ Austin, TX ................................................. 2,171,142 

His House ..................................................................................................................... Opa Locka, FL .......................................... 950,000 

Lincoln Hall ................................................................................................................... Lincolndale, NY ......................................... 523,520 

Youth For Tomorrow .................................................................................................... Bristow, VA ............................................... 1,118,067 

These supplement grants will support 

the expansion of bed capacity and 

supportive services to meet the number 

of unaccompanied alien children 

referrals from the Department of 

Homeland Security (DHS). The funding 

program is mandated by section 462 of 

the Homeland Security Act to ensure 

appropriate placement of all referrals 

from the DHS. The program is tied to 

DHS apprehension strategies and 

sporadic number of border crossers. 

Award funds will support services to 

unaccompanied alien children through 

September 30, 2013. 

DATES: The period of support under 

these supplements is October 1, 2012 

through September 30, 2013. 

FOR FURTHER INFORMATION CONTACT: 

Jallyn Sualog, Acting Director, Division 

of Children’s Services, Office of Refugee 

Resettlement, 901 D Street SW., 

Washington, Telephone (202) 401–4997. 

Email:jallyn.sualog@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: Since the 

beginning of FY 13, the Unaccompanied 

Alien Children (UAC) program has seen 

a dramatic increase in the number of 

DHS referrals. The influx of border 

crossers referred by DHS has grown 

beyond anticipated rates and has 

resulted in the program needing a 

significant increase in the number of 

shelter beds and supportive services. 

The UAC program has specific 

requirements for the provision of 

services to unaccompanied alien 

children. These grantee organizations 

are the only entities with the 

infrastructure, licensing, experience, 

and appropriate level of trained staff to 

meet the required service requirements 

and the urgent need for the expansion 

of services required to respond to 

unexpected arrivals of unaccompanied 

children. The program expansion 

supplement will support such services 

and alleviate the buildup of children 

waiting in border patrol stations for 

placement in shelter care. 

Statutory Authority: Section 462 of the 

Homeland Security Act, (6 U.S.C. 279) and 

sections 235(c) and 235(d) of the William 

Wilberforce Trafficking Victims Protection 

Reauthorization Act of 2008, (8 U.S.C. 

1232(c) and 1232(d)). 

Eskinder Negash, 

Director, Office of Refugee Resettlement. 

[FR Doc. 2013–09699 Filed 4–23–13; 8:45 am] 

BILLING CODE 4184–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2013–N–0403] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Protection of 

Human Subjects: Informed Consent; 

Institutional Review Boards 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the regulations that provide protection 

for human subjects of clinical 

investigations conducted in support of 

applications or submissions to FDA for 

FDA-regulated products. The 

regulations provide protection of the 

rights, safety, and welfare of human 

subjects involved in research activities 

within FDA’s jurisdiction. 

DATES: Submit either electronic or 

written comments on the collection of 

information by June 24, 2013. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 


tkelley on DSK3SPTVN1PROD with NOTICES